Patents Assigned to Aktiebolaget Draco
-
Patent number: 4524769Abstract: A powder inhalator which is activated by the air flow generated at inhalation and which is intended for inhalation of solid pharmacologically active compound in micronized form, said inhalator comprising a nozzle 2, an air conduit 6, a dosing unit 10 comprising a storage chamber 5 for the active compound and dosing means 8, and a maneuvering unit 1, characterized in that the dosing unit 10 comprises a storage chamber 5 for the active compound, a perforated membrane 4, a holder 9 for the said perforated membrane, and dosing means 8 for introducing active compound into the perforations in the perforated membrane 4, whereby means are arranged for displacing the membrane 4 in relation to the dosing means 8, whereby in a first position solid active compound in micronized form is introduced into the perforations in part of the area of the membrane 4 and in a second position the said part of the membrane 4 is inserted in the air conduit 6 for the air to be inhaled.Type: GrantFiled: June 17, 1982Date of Patent: June 25, 1985Assignee: Aktiebolaget DracoInventor: Kjell I. L. Wetterlin
-
Patent number: 4451663Abstract: New bronchospasmolytically active compounds exhibiting long duration of action and reduced undesired side effects of the structural formula ##STR1## and therapeutically acceptable salts thereof, in which formula R is selected from the group consisting of --C(CH.sub.3).sub.3, ##STR2## R.sup.1 is selected from the group consisting of H and R.sup.2, R.sup.2 represents the radical of the formula ##STR3## wherein R.sup.3 is selected from the group consisting of(a) H(b) alkyl groups containing 1-3 carbon atoms ##STR4## wherein R.sup.5 is selected from the group consisting of(a) OH(b) alkoxy groups containing 1-3 carbon atoms and whereinR.sup.4 is selected from the group consisting of(a) H(b) alkyl groups containing 1-3 carbon atoms, with the proviso that R.sup.3 and R.sup.4 are combined as follows:______________________________________ when R.sup.3 is then R.sup.Type: GrantFiled: July 6, 1982Date of Patent: May 29, 1984Assignee: Aktiebolaget DracoInventors: O. A. Torsten Olsson, Leif A. Svensson, Kjell I. L. Wetterlin
-
Patent number: 4442300Abstract: New bronchospasmolytically active compounds exhibiting long duration of action and reduced undesired side effects, of the structural formula ##STR1## and therapeutically acceptable salts thereof, in which formula R, R.sup.1 and R.sup.2 are as follows:R is selected from the group consisting of --C(CH.sub.3).sub.3, ##STR2## R.sup.1 is selected from the group consisting of H and R.sup.2 ; R.sup.2 is selected from the group consisting of ##STR3## in which formulas R.sup.3 is selected from the group consisting of (a) H; ##STR4## wherein R.sup.5 is a straight or branched alkyl group containing 1-4 carbon atoms;and ##STR5## and wherein R.sup.4 is selected from the group consisting of(a) H(b) an alkyl group containing 1-3 carbon atoms,process for the preparation thereof, chemical intermediates at their preparation, pharmaceutical compositions containing them and their medicinal use.Type: GrantFiled: July 1, 1981Date of Patent: April 10, 1984Assignee: Aktiebolaget DracoInventors: O. A. Torsten Olsson, Leif .ANG. Svensson, Kjell I. L. Wetterlin
-
Patent number: 4419364Abstract: New bronchospasmolytically active compounds exhibiting long duration of action and reduced undesired side effects of the structural formula ##STR1## and therapeutically acceptable salts thereof, in which formula R is selected from the group consisting of --C(CH.sub.3).sub.3, ##STR2## R.sup.1 is selected from the group consisting of H and R.sup.2, R.sup.2 represents the radical of the formula ##STR3## wherein R.sup.3 is selected from the group consisting of (a) H(b) alkyl groups containing 1-3 carbon atoms ##STR4## wherein R.sup.5 is selected from the group consisting of (e) OH(b) alkoxy groups containing 1-3 carbon atoms and whereinR.sup.4 is selected from the group consisting of(a) H(b) alkyl groups containing 1-3 carbon atoms, with the proviso that R.sup.3 and R.sup.4 are combined as follows:______________________________________ when R.sup.3 is then is R.sup.Type: GrantFiled: July 1, 1981Date of Patent: December 6, 1983Assignee: Aktiebolaget DracoInventors: O. A. Torsten Olsson, Leif A. Svensson, Kjell I. L. Wetterlin
-
Patent number: 4404200Abstract: The invention refers to compounds having anti-inflammatory activity, characterized by the formula ##STR1## in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents at the carbon atom in position 22, in which formula A is n-propyl or n-butyl and Z is hydroxyl or hydroxyl esterified with a fatty acid with a straight or branched hydrocarbon chain having 1-5 carbon atoms.The invention also refers to a process for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment and control of inflammatory conditions.Type: GrantFiled: November 17, 1981Date of Patent: September 13, 1983Assignee: Aktiebolaget DracoInventors: Bror A. Thalen, Ralph L. Brattsand
-
Patent number: 4363806Abstract: A pharmaceutical steroid composition for topical application producing a minimum of skin irritating effects. The composition comprises a corticosteroid in a multiple emulsion vehicle.A process for the preparation of the composition.Type: GrantFiled: June 12, 1981Date of Patent: December 14, 1982Assignee: Aktiebolaget DracoInventors: Karl O. Bergstrom, Jan Ulmius, Bo L. T. Wenngren
-
Patent number: 4338319Abstract: A method for the treatment of chronic obstructive airway disease or cardiac disease by administration 3-ethylxantine or a pharmaceutically acceptable salt thereof; a pharmaceutical preparation containing 3-ethylxanthine.Type: GrantFiled: November 21, 1980Date of Patent: July 6, 1982Assignee: Aktiebolaget DracoInventors: Per G. Kjellin, Carl G. A. Persson
-
Patent number: 4325956Abstract: A method for the treatment of chronic obstructive airway disease or cardiac disease, characterized by the administration of a compound of the formula ##STR1## wherein R is n-propyl, n-butyl or isobutyl or a therapeutically acceptable salt thereof.Type: GrantFiled: October 5, 1979Date of Patent: April 20, 1982Assignee: Aktiebolaget DracoInventors: Per G. Kjellin, Carl G. A. Persson
-
Patent number: 4292966Abstract: An aerosol inhalation device comprising an elongated chamber, an outer chamber part of which has an outlet opening and is telescopically displaceable over an inner chamber part which is connectable to an aerosol dispenser and provided with a flexible tongue which on telescoping the device together closes the outlet opening.Type: GrantFiled: February 5, 1980Date of Patent: October 6, 1981Assignee: Aktiebolaget DracoInventors: Rune G. Mono, Nils F. E. Moren, Kjell I. L. Wetterlin
-
Patent number: 4292324Abstract: A pharmaceutical composition containing zinc in the form of one or more water soluble zinc salts and a complex-former selected from the group consisting of hydroxycarboxylic acids, acid anhydrides, or salts thereof. The water solutions thereof give a palatable, acceptable peroral zinc solution and are useful for treating leg ulcers, post-operative wounds, decubital ulcers and other diseased conditions in zinc anemia.Type: GrantFiled: March 19, 1979Date of Patent: September 29, 1981Assignee: Aktiebolaget DracoInventors: Karl E. Jonsson, Nils F. E. Moren
-
Patent number: 4233303Abstract: Compounds of the formula ##STR1## or physiologically acceptable salts thereof in which formula R.sup.1 is methyl, ethyl or n-propyl, R.sup.2 is methyl or n-propyl and R.sup.3 is ##STR2## methods for the preparation thereof; intermediates useful for their preparation; pharmaceutical preparations containing at least one of these compounds; and the use thereof in the treatment of allergy and bronchial asthma.Type: GrantFiled: September 29, 1978Date of Patent: November 11, 1980Assignee: Aktiebolaget DracoInventors: Sten H. A. M. Bergstrand, Per G. Kjellin, Carl G. A. Persson, Lars M. Sorenby
-
Patent number: 4225614Abstract: A method for treating mucocutaneous herpes simplex infections in man or other animals susceptible to said infections comprising the administration of an amount of zinc in the form of a salt or a hydroxycarboxylic acid or aminocarboxylic acid complex thereof, therapeutically effective in the treatment of said infections.Type: GrantFiled: December 14, 1978Date of Patent: September 30, 1980Assignee: Aktiebolaget DracoInventor: Anders E. Hansson
-
Patent number: 4174712Abstract: A device for use with a medicinal inhalation device comprises a rotationally symmetrical chamber having an opening to be connected to a spray nozzle and a mouthpiece. The chamber diverges conically from the opening and converges towards the mouthpiece. During passage through the chamber, an aerosol mist will lose propellant by evaporation, and smaller particles will be generated which can more readily follow the path of inhalation.Type: GrantFiled: November 7, 1977Date of Patent: November 20, 1979Assignee: Aktiebolaget DracoInventors: Nils F. E. Moren, Kjell I. L. Wetterlin
-
Patent number: 4137914Abstract: An aerosol inhalation device is designed to use a capsule having a single dose of medication and a propellant. The device includes a hollow needle which perforates the capsule to release the medication. The capsules used with the device include a single dose of medication and an appropriate quantity of propellant.Type: GrantFiled: December 10, 1976Date of Patent: February 6, 1979Assignee: Aktiebolaget DracoInventor: Kjell I. L. Wetterlin
-
Patent number: 4114615Abstract: An aerosol inhalation device for dispensing medicine makes use of separate propellant and medicine containers. A valve is provided, which acts in conjunction with a metering chamber, to supply a measured amount of propellant upon each activation of the device.Type: GrantFiled: December 10, 1976Date of Patent: September 19, 1978Assignee: Aktiebolaget DracoInventor: Kjell Ingvar Leopold Wetterlin
-
Patent number: 4011258Abstract: Novel compounds are disclosed having useful activity as bronchodilators of improved longevity of action and reduced incidence of side effects. These compounds are described by the formula: ##STR1## wherein R.sub.1 is a member of the class consisting of tertiary butyl and cyclobutyl, and R.sub.2 is a hydrogen or 2 to 5 carbon atom acyl radical, and pharmaceutically acceptable salts thereof. The activity of these compounds is compared to previously known bronchodilators such as 1-(3', 5'-dihydroxyphenyl)-2-(isopropylamino)-ethanol, having the common name orciprenaline, and 1-(3', 4'-dihydroxyphenyl-2-isopropylamino-ethanol, having the common name isoprenaline.Type: GrantFiled: July 7, 1975Date of Patent: March 8, 1977Assignee: Aktiebolaget DracoInventors: Kjell Ingvar Leopold Wetterlin, Leif Ake Svensson
-
Patent number: 3937838Abstract: Novel compounds are disclosed having useful activity as bronchodilators of improved longevity of action and reduced incidence of side effects. These compounds are described by the formula: ##EQU1## wherein R.sub.1 is a member of the class consisting of tertiary butyl and cyclobutyl, and R.sub.2 is a hydrogen or 2 to 5 carbon atom acyl radical, and pharmaceutically acceptable salts thereof. The activity of these compounds is compared to previously known bronchodilators such as 1-(3', 5'-dihydroxyphenyl)-2-(isopropylamino)-ethanol, having the common name orciprenaline, and 1-(3', 4'-dihydroxyphenyl-2-isoproplyamino-ethanol, having the common name isoprenaline.Type: GrantFiled: June 21, 1973Date of Patent: February 10, 1976Assignee: Aktiebolaget DracoInventors: Kjell Ingvar Leopold Wetterlin, Leif Ake Svensson
-
Patent number: D262320Type: GrantFiled: July 11, 1979Date of Patent: December 15, 1981Assignee: Aktiebolaget DracoInventor: Rune G. Mono
-
Patent number: D276654Type: GrantFiled: March 11, 1982Date of Patent: December 4, 1984Assignee: Aktiebolaget DracoInventors: Kaija A. Snellman-Wasenius, Risto Virtanen
-
Patent number: D276847Type: GrantFiled: March 11, 1982Date of Patent: December 18, 1984Assignee: Aktiebolaget DracoInventors: Sven G. Nyman, Kaija A. Snellman-Wasenius, Risto Virtanen